A New J-Resolved MRSI Framework for Whole-Brain Simultaneous Metabolite and Neurotransmitter Mapping
用于全脑同步代谢物和神经递质图谱的新 J-Resolved MRSI 框架
基本信息
- 批准号:10057847
- 负责人:
- 金额:$ 56.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlgorithmic SoftwareBasic ScienceBiochemicalBiological MarkersBrainBrain MappingBrain imagingClinicalComputer SimulationContrast MediaCouplingDataDiagnosisDimensionsDiseaseEquationEvaluationEvolutionExperimental DesignsFoundationsFunctional Magnetic Resonance ImagingFutureGoalsImageImaging TechniquesImaging problemImaging technologyLearningMachine LearningMapsMechanicsMetabolicMethodsModalityModelingMolecularMonitorNerve DegenerationNeurodegenerative DisordersNeurologicNeurotransmittersNoiseOrganPathologicPatientsPhysicsPhysiologic pulsePhysiologicalPhysiological ProcessesProcessReproducibilityResearchResolutionSamplingScanningSchemeScientistSclerosisSignal TransductionSoftware ToolsSolidSpectrum AnalysisSpeedTechnologyTemporal Lobe EpilepsyTimeTissuesTrainingValidationVariantWaterbaseclinical applicationclinical translationcomputerized data processingdeep neural networkdesignexperimental studyhealthy volunteerhigh dimensionalityimaging studyimprovedin vivoinnovationinterestmagnetic fieldmagnetic resonance spectroscopic imagingmolecular imagingnervous system disorderneuroimagingnovelnovel strategiespatient populationpotential biomarkerquantumreconstructionrelating to nervous systemsimulationspectroscopic imagingsuccesstool
项目摘要
PROJECT SUMMARY/ABSTRACT
The metabolite and neurotransmitter profiles of neural tissues provide a unique window into brain’s
physiological state and can be used to extract potential biomarkers for detecting and characterizing
neurodegenerative diseases. Magnetic resonance spectroscopic imaging (MRSI) allows simultaneous
mapping and quantification of a number of metabolites and neurotransmitters without exogenous
contrast agents thus promised tremendous opportunities for molecular imaging of the brain. However,
due to several fundamental technical challenges, including low SNR, poor spatial resolution, long
imaging time and inaccurate separation of spectrally overlapping molecular signals, most in vivo MRSI
studies to date are still limited to very low-resolution experiments (~1cm3 voxel size) with small brain
coverages. The primary goal of this proposed research is to develop, optimize and evaluate a new
framework to model, acquire and process MRSI data to enable simultaneous, high-resolution, whole-
brain mapping of metabolites and neurotransmitters in clinically feasible time. To achieve this goal, in
Aim 1, we will design and implement a novel acquisition strategy that synergistically combines SNR-
efficient, multi-slab and multi-TE excitation, sparse sampling in a (k,t,TE)-space and optimized TE
selection with maximum echo sampling to generate J-resolved (multi-TE) MRSI data with an
unprecedented combination of speed, resolution and organ coverage. In Aim 2, we will develop novel
nonlinear low-dimensional models of general MR spectra using a learning-based strategy that integrates
the biochemical priors of neural tissues, known physics-based MRSI signal modeling and deep neural
networks. These learned models will effectively reduce the dimensionality of the imaging problem and
allow for significantly improved speed, resolution and SNR tradeoffs as well as signal separation. Novel
computational solutions that effectively exploit the learned models and other spatial-spectral-TE
constraints will be developed for spatiospectral reconstruction of metabolites and neurotransmitters from
the noisy, high-resolution J-resolved MRSI data. Finally, in Aim 3, we will systematically evaluate the
proposed technology in terms of speed, resolution, SNR, and quantitative accuracy using computer
simulations, phantom and in vivo experiments. The feasibility and robustness of the proposed technology
for mapping metabolites and neurotransmitters in both healthy volunteers and temporal lobe epilepsy
patients with mesial temporal sclerosis will be demonstrated. The success of the proposed research will
lead to significant progress for in vivo MRSI and represent an important step towards the creation of a
powerful tool for studying the molecular basis of brain functions and diseases. This tool, when fully
developed, will add a transformative dimension to the existing neuroimaging technology profiles, with
the potential to impact the diagnosis and management of neurological and neurodegenerative diseases.
项目摘要/摘要
神经疗法的代谢物和神经递质轮廓为大脑的独特窗口提供了独特的窗口
物理状态,可用于提取潜在的生物标志物来检测和表征
神经退行性疾病。磁共振光谱成像(MRSI)允许同时进行
许多代谢物和神经递质的映射和定量没有外源
因此,对比剂承诺为大脑的分子成像带来巨大的机会。然而,
由于几个基本的技术挑战,包括低SNR,空间分辨率差,很长
成像时间和光谱重叠分子信号的不准确分离,大多数体内MRSI
迄今为止的研究仍然仅限于非常低分辨率的实验(〜1cm3 Voxel大小)
覆盖范围。这项拟议研究的主要目标是开发,优化和评估新的
建模,获取和处理MRSI数据的框架以实现简单,高分辨率,整体
在临床上可行的时间内代谢物和神经递质的脑图。为了实现这一目标,
AIM 1,我们将设计和实施一种新颖的采集策略,从而协同结合SNR-
在A(k,t,te)空间和优化的TE中,有效,多斜线和多TE的兴奋,稀疏采样
使用最大回声采样的选择以生成J分解(多TE)MRSI数据
速度,分辨率和器官覆盖率的前所未有的组合。在AIM 2中,我们将开发小说
使用基于学习的策略的一般MR光谱的非线性低维模型
神经疗法的生化先验,已知的基于物理学的MRSI信号建模和深神经检查
网络。这些学习的模型将有效地降低成像问题的维度和
允许显着提高速度,分辨率和SNR权衡以及信号分离。小说
有效探索学习模型和其他空间光谱-TE的计算解决方案
将开发出限制因素,用于从事代谢物和神经递质从
噪声,高分辨率J分解的MRSI数据。最后,在AIM 3中,我们将系统地评估
在使用计算机的速度,分辨率,SNR和定量准确性方面提议的技术
模拟,幻影和体内实验。拟议技术的可行性和鲁棒性
用于映射健康志愿者和临时叶癫痫的代谢物和神经递质
将证明患有介内暂时性硬化症的患者。拟议研究的成功将
导致体内MRSI取得重大进展,并代表了创建一个重要的一步
研究大脑功能和疾病的分子基础的强大工具。该工具完全
开发的,将为现有的神经影像技术概况增加一个变革性的维度
影响神经和神经退行性疾病的诊断和管理的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fan Lam其他文献
Fan Lam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fan Lam', 18)}}的其他基金
High-Throughput 3D Multiscale Mass Spectrometry Imaging for Understanding Neurochemical Heterogeneity in Alzheimer's Disease
高通量 3D 多尺度质谱成像用于了解阿尔茨海默病的神经化学异质性
- 批准号:
10704657 - 财政年份:2022
- 资助金额:
$ 56.55万 - 项目类别:
High-Throughput 3D Multiscale Mass Spectrometry Imaging for Understanding Neurochemical Heterogeneity in Alzheimer's Disease
高通量 3D 多尺度质谱成像用于了解阿尔茨海默病的神经化学异质性
- 批准号:
10516527 - 财政年份:2022
- 资助金额:
$ 56.55万 - 项目类别:
相似国自然基金
高吞吐低时延的多元LDPC码译码算法及其软件架构研究
- 批准号:62301029
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深度学习中的流形优化问题:算法设计与求解软件包的开发
- 批准号:12301408
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
能量一阶导数的GPU算法和异构并行计算:WESP软件的发展和向国产异构平台的移植
- 批准号:22373112
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
机理与数据耦合驱动的AI赋能工业软件理论与算法
- 批准号:52335001
- 批准年份:2023
- 资助金额:230 万元
- 项目类别:重点项目
面向量子模拟算法的量子软件优化技术研究
- 批准号:62302395
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A de novo approach to detect and interrogate neglected HIV diversity
检测和询问被忽视的艾滋病毒多样性的从头方法
- 批准号:
10402978 - 财政年份:2021
- 资助金额:
$ 56.55万 - 项目类别:
An informatics framework for SUDEP Risk Marker Identification and Risk Assessment
SUDEP 风险标记识别和风险评估的信息学框架
- 批准号:
10393043 - 财政年份:2020
- 资助金额:
$ 56.55万 - 项目类别:
An informatics framework for SUDEP Risk Marker Identification and Risk Assessment
SUDEP 风险标记识别和风险评估的信息学框架
- 批准号:
10163933 - 财政年份:2020
- 资助金额:
$ 56.55万 - 项目类别: